微电生理
(688351)
| 流通市值：25.33亿 | | | 总市值：95.48亿 |
| 流通股本：1.25亿 | | | 总股本：4.71亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 104,099,813.81 | 413,166,794.49 | 290,866,132.55 | 198,364,587.44 |
| 营业收入 | 104,099,813.81 | 413,166,794.49 | 290,866,132.55 | 198,364,587.44 |
| 二、营业总成本 | 92,572,167.93 | 401,537,623.37 | 287,957,417.1 | 194,365,348.26 |
| 营业成本 | 41,052,440.47 | 170,519,238.94 | 119,862,505.9 | 81,133,735.61 |
| 税金及附加 | 1,023,678.65 | 3,128,777.07 | 2,687,180.33 | 1,948,856.31 |
| 销售费用 | 27,366,770.2 | 110,860,672.58 | 80,636,977.44 | 54,840,835.58 |
| 管理费用 | 11,320,386.3 | 42,638,056.89 | 29,905,134.19 | 19,861,527.57 |
| 研发费用 | 13,417,634.91 | 77,401,893.01 | 56,543,925.34 | 38,520,834.59 |
| 财务费用 | -1,608,742.6 | -3,011,015.12 | -1,678,306.1 | -1,940,441.4 |
| 其中:利息费用 | 105,677.23 | 886,734.64 | 712,180.93 | 499,430.21 |
| 其中:利息收入 | 1,088,047.28 | 4,102,580.22 | 3,601,493.58 | 2,859,658.46 |
| 加:公允价值变动收益 | 2,560,608.33 | 11,430,173.67 | 9,040,559.74 | 6,385,674.19 |
| 加:投资收益 | 1,807,889.66 | 8,983,819.55 | 6,648,248.47 | 4,355,372.72 |
| 资产处置收益 | 726,244.5 | -33,969.45 | - | - |
| 资产减值损失(新) | -790,521.71 | -2,971,800.66 | -2,339,522.09 | -2,107,352.74 |
| 信用减值损失(新) | 59,365.67 | -1,270,362.46 | -143,488.45 | -153,238.67 |
| 其他收益 | 2,041,065.69 | 26,757,938.19 | 27,840,968.03 | 6,790,440.83 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 17,932,298.02 | 54,524,969.96 | 43,955,481.15 | 19,270,135.51 |
| 加:营业外收入 | - | 23,661 | 23,661 | - |
| 减:营业外支出 | 60 | 2,422,759.89 | 2,237,402.59 | 2,237,402.59 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 17,932,238.02 | 52,125,871.07 | 41,741,739.56 | 17,032,732.92 |
| 减:所得税费用 | 61,743.88 | 55,508.74 | 15,086.76 | 20,062.24 |
| 六、净利润 | 17,870,494.14 | 52,070,362.33 | 41,726,652.8 | 17,012,670.68 |
| 持续经营净利润 | 17,870,494.14 | 52,070,362.33 | 41,726,652.8 | 17,012,670.68 |
| 归属于母公司股东的净利润 | 17,870,494.14 | 52,070,362.33 | 41,726,652.8 | 17,012,670.68 |
| (一)基本每股收益 | 0.04 | 0.11 | 0.09 | 0.04 |
| (二)稀释每股收益 | 0.04 | 0.11 | 0.09 | 0.04 |
| 八、其他综合收益 | -1,423.97 | 1,450.96 | 522.72 | - |
| 归属于母公司股东的其他综合收益 | -1,423.97 | 1,450.96 | 522.72 | - |
| 九、综合收益总额 | 17,869,070.17 | 52,071,813.29 | 41,727,175.52 | 17,012,670.68 |
| 归属于母公司股东的综合收益总额 | 17,869,070.17 | 52,071,813.29 | 41,727,175.52 | 17,012,670.68 |
| 公告日期 | 2025-04-30 | 2025-03-28 | 2024-10-22 | 2024-08-22 |
| 审计意见(境内) | | 标准无保留意见 | | |